We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock
FMTX

Delisted

FMTX was delisted on the 13th of October, 2022.

Back to rankings

98 hedge funds and large institutions have $385M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 12

33% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 27

5% more funds holding

Funds holding: 93 → 98 (+5)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

34% less capital invested

Capital invested by funds: $587M → $385M (-$202M)

89% less call options, than puts

Call options by funds: $95K | Put options by funds: $843K

Holders
98
Holders Change
+5
Holders Change %
+5.38%
% of All Funds
1.55%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
36
Reduced
27
Closed
12
Calls
$95K
Puts
$843K
Net Calls
-$748K
Net Calls Change
-$733K

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$17.7M
2
AC
Armistice Capital
New York
+$14.3M
3
State Street
State Street
Massachusetts
+$10.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$3.73M
5
Morgan Stanley
Morgan Stanley
New York
+$3.67M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$25M
2
LGM
Logos Global Management
California
-$22.8M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$6.41M
4
CAM
Cormorant Asset Management
Massachusetts
-$6.08M
5
Deutsche Bank
Deutsche Bank
Germany
-$5.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$83.8M – – –
CAM
2
Cormorant Asset Management
Massachusetts
$37.8M -$6.08M -571,644 -12%
AC
3
Armistice Capital
New York
$29.8M +$14.3M +1,344,000 +72%
BlackRock
4
BlackRock
New York
$28.1M -$89.2K -8,381 -0.3%
State Street
5
State Street
Massachusetts
$26.1M +$10.6M +999,479 +55%
Vanguard Group
6
Vanguard Group
Pennsylvania
$21M -$6.41M -601,897 -21%
BBA
7
Baker Bros. Advisors
New York
$18.8M – – –
DTC
8
Deep Track Capital
Connecticut
$15.4M +$17.7M +1,659,706 New
SB
9
Samsara BioCapital
California
$14.6M – – –
Fidelity Investments
10
Fidelity Investments
Massachusetts
$14.2M -$25M -2,352,990 -61%
EPL
11
EDBI Pte Ltd
Singapore
$11.8M – – –
HA
12
HHLR Advisors
Cayman Islands
$10.2M – – –
AG
13
Artal Group
Luxembourg
$9.3M – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$5.95M +$3.22M +302,300 +89%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$5.25M +$112K +10,536 +2%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$5.22M -$366K -34,400 -6%
Morgan Stanley
17
Morgan Stanley
New York
$4.79M +$3.67M +344,746 +202%
Citadel Advisors
18
Citadel Advisors
Florida
$3.91M +$3.73M +349,997 +499%
Northern Trust
19
Northern Trust
Illinois
$2.89M -$24.4K -2,293 -0.7%
CS
20
Candriam SCA
Luxembourg
$2.72M – – –
Goldman Sachs
21
Goldman Sachs
New York
$2.41M -$150K -14,117 -5%
Charles Schwab
22
Charles Schwab
California
$2.05M -$90.4K -8,494 -4%
Millennium Management
23
Millennium Management
New York
$2M +$1.74M +163,365 +316%
Two Sigma Investments
24
Two Sigma Investments
New York
$1.93M +$1.47M +137,979 +199%
Rafferty Asset Management
25
Rafferty Asset Management
New York
$1.56M +$547K +51,358 +44%
1
2 3 4 5

FMTX Hedge Fund Activity: Q1 2022 in Review

98 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q1 2022, worth a combined $385M — down 34% from $587M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new FMTX positions and 12 closed out — a net gain of 5 holders — while 36 added to existing stakes and 27 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $17.7M. The largest seller was Fidelity Investments, cutting an estimated $25M.

  • 98 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q1 2022, up from 93 in Q4 2021.
  • Funds reported $385M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q1 2022, down 34% quarter-over-quarter.
  • 17 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q1 2022 and 12 closed out, a net change of +5 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q1 2022 was Deep Track Capital, an estimated $17.7M added.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q1 2022 was Fidelity Investments, an estimated $25M sold.

Based on aggregated 13F filings for Q1 2022.